Search

Your search keyword '"Chamoun, Mira"' showing total 604 results

Search Constraints

Start Over You searched for: Author "Chamoun, Mira" Remove constraint Author: "Chamoun, Mira"
604 results on '"Chamoun, Mira"'

Search Results

2. Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging

3. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

4. 14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

5. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

6. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging

9. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

10. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

11. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals

12. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease

14. Microglial activation and tau propagate jointly across Braak stages

15. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

16. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease.

19. The Forgetful Golfer

21. Concerns about the Future

23. A Young Man with Memory and Walking Difficulties

24. A Young Missionary with Problems Quoting the Bible

25. A Challenging Thesis

26. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease

27. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease

28. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation

29. Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies

30. Sex impacts the association of plasma Glial Fibrillary Acidic Protein with neurodegeneration in Alzheimer’s disease

31. Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators

32. 14-3-3 $$\upzeta /\updelta$$-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

33. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages

35. APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles

37. Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET

38. Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals.

39. Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease

40. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden

42. Medial Temporal Tau Predicts Memory Decline in Cognitively Unimpaired Elderly (P5-6.011)

43. APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

45. Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology

46. APOEε4 potentiates Aβ effects on longitudinal tangle accumulation via tau phosphorylation

47. Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease

48. Additional file 1 of CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals

49. Medial temporal tau predicts memory decline in cognitively unimpaired elderly

50. Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles

Catalog

Books, media, physical & digital resources